ConferencePoster
 (2024)

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer

Pignata, Sandro; Sukhin, Vladyslav; Colombo, Nicoletta; Korach, Jacob; Matsumoto, Takashi; Lalondrelle, Susan; Vizkeleti, Julia; Randall, Leslie; Samouelian, Vanessa; Salman, Pamela et al.